Gastrointestinal Oncology
A section of Current Oncology (ISSN 1718-7729).
Section Information
Keywords
- Epidemiology/risk factors
- Screening and prevention
- Diagnostic approaches and technologies
- Precision oncology, biomarkers
- Novel treatment approaches
- Clinical trials and real-world studies
- Research on health services and care delivery
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Integrative and Multi-Modality Therapy in the Next Generation of Hepatocellular Carcinoma Management (Deadline: 31 October 2024)
- New Treatments in Pancreatic Ductal Adenocarcinoma (Deadline: 31 October 2024)
- New Frontiers in Treatment of Pancreatic Cancer (Deadline: 15 November 2024)
- Novel Targeted Therapy, Immunotherapy, and Immune Biomarkers for Gastroesophageal and Liver Cancer (Deadline: 31 December 2024)
- Biliary Tract Cancer Updates: Advancements and Insights (Deadline: 31 December 2024)
- Gastrointestinal Cancers in Eastern Canada (Deadline: 31 December 2024)
- Novel Biomarkers and Liver Cancer (Deadline: 15 January 2025)
- Radioembolization for Hepatocellular Carcinoma (Deadline: 10 February 2025)
- Biomarkers and Precision Medicine in Upper Gastrointestinal Malignancies (Deadline: 30 April 2025)
- Recent Advances in Surgical Strategies for Managing Metastatic Colorectal Cancer (Deadline: 15 May 2025)
- Research on Neoadjuvant Therapy for Gastric Cancer (Deadline: 31 May 2025)
- Therapeutic Studies from Pre-Clinical to Clinical (Phase I–IV) for Gastrointestinal Cancers (Deadline: 30 June 2025)
- Histological and Molecular Subtype of Pancreatic Cancer (Deadline: 31 July 2025)